Patents by Inventor Guy Anthony Kennett

Guy Anthony Kennett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
    Patent number: 6664229
    Abstract: Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose or treat diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition, methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment by administering the identified agonists or antagonists to patients in need thereof are further disclosed.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: December 16, 2003
    Assignee: SmithKline Beecham p.l.c.
    Inventors: James Joseph Hagan, Jonathan Alexander Terrett, Neil Upton, David Piper, Martin Ian Smith, Guy Anthony Kennett, Saraswati R. Patel
  • Fused indole derivatives
    Patent number: 6610685
    Abstract: The present invention is a chemical compound of formula (I) or a pharmaceutically acceptable salt, solvate and ester thereof, wherein R1 to R4 and n are as defined in the specification. A compound of formula 1 is useful as a pharmaceutical composition for the treatment or prevention of disorders of the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: August 26, 2003
    Assignees: Hoffmann-La Roche Inc., Vernalis Research Limited
    Inventors: Jonathan Mark Bentley, Michael John Bickerdike, Paul Hebeisen, Guy Anthony Kennett, Sean Lightowler, Patrizio Mattei, Jacques Mizrahi, Timothy James Morley, Jean-Marc Plancher, Hans Richter, Stephan Roever, Sven Taylor, Steven Paul Vickers
  • METHODS FOR TREATMENT USING NOVEL LIGANDS OF THE NEUROPEPTIDE RECEPTOR HFGAN72
    Publication number: 20030087801
    Abstract: Polypeptides of HFGAN72 receptor ligands and polynucleotides encoding the polypeptides are provided. Methods of using these polypeptides to diagnose or treat diseases relating to the under- or over-expression of HFGAN72 receptor ligands are also provided. In addition, methods of identifying agonists or antagonists of the interaction of HFGAN72 receptor ligands with the HFGAN72 receptor are provided. Methods of treatment by administering the identified agonists or antagonists to patients in need thereof are further disclosed.
    Type: Application
    Filed: December 15, 1998
    Publication date: May 8, 2003
    Inventors: JAMES JOSEPH HAGAN, JONATHAN ALEXANDER TERRETT, NEIL UPTON, DAVID PIPER, MARTIN IAN SMITH, GUY ANTHONY KENNETT, SARASWATI R. PATEL
  • Novel indole derivatives
    Publication number: 20020160997
    Abstract: The present invention is a chemical compound of formula (I) 1
    Type: Application
    Filed: December 14, 2001
    Publication date: October 31, 2002
    Inventors: Jonathan Mark Bentley, Michael John Bickerdike, Paul Hebeisen, Guy Anthony Kennett, Sean Lightowler, Patrizio Mattei, Jacques Mizrahi, Timothy James Morley, Jean-Marc Plancher, Hans Richter, Stephan Roever, Sven Taylor, Steven Paul Vickers
  • Medicaments for the treatment of anxiety
    Patent number: 5763459
    Abstract: A method for the treatment of anxiety in mammals comprises administering an effective amount of a 5-HT.sub.4 receptor antagonist.
    Type: Grant
    Filed: February 28, 1995
    Date of Patent: June 9, 1998
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Gordon Smith Baxter, Guy Anthony Kennett